Intra-Cellular Therapies
ITCI
#1974
Rank
โ‚ฌ7.40 B
Marketcap
70,04ย โ‚ฌ
Share price
0.83%
Change (1 day)
37.17%
Change (1 year)

Market capitalization of Intra-Cellular Therapies (ITCI)

Market cap: โ‚ฌ7.40 Billion

As of September 2024 Intra-Cellular Therapies has a market cap of โ‚ฌ7.40 Billion. This makes Intra-Cellular Therapies the world's 1974th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Intra-Cellular Therapies from 2013 to 2024

End of year Market Cap

Year Market cap Change
2024โ‚ฌ7.40 B18.69%
2023โ‚ฌ6.23 B33.45%
2022โ‚ฌ4.67 B24.67%
2021โ‚ฌ3.74 B79.04%
2020โ‚ฌ2.09 B23.41%
2019โ‚ฌ1.69 B210.75%
2018โ‚ฌ0.54 B-17.13%
2017โ‚ฌ0.65 B6.11%
2016โ‚ฌ0.62 B-70.81%
2015โ‚ฌ2.12 B397.14%
2014โ‚ฌ0.42 B33.33%
2013โ‚ฌ0.32 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Intra-Cellular Therapies was reported to be:

โ‚ฌ7.40 Billion
by Yahoo Finance info icon info icon
โ‚ฌ7.40 Billion
by CompaniesMarketCap info icon info icon
โ‚ฌ7.40 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
โ‚ฌ84.09 M-98.86%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ31.88 M-99.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.32 B-82.03%๐Ÿ‡บ๐Ÿ‡ธ USA